Trinity Biotech Collaborating With Latch Medical on Metabolic Health Technology

MT Newswires Live

Jul 22

Trinity Biotech (TRIB) said Wednesday it is collaborating with Latch Medical to develop precision therapeutic solutions for diabetes, obesity and other metabolic conditions.

The companies plan to integrate Trinity's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to explore how real-time metabolic data can be used to help guide and optimize therapeutic delivery.

Financial terms of the collaboration not disclosed.

Trinity Biotech also agreed in principle to make a strategic equity investment in Latch Medical as part of the collaboration, the company said.

Trinity Biotech shares were down 23% in premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2653175078"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2653175078\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2653175078?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 20:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653175078","market":"nz","top_or_hot":-1,"title":"Trinity Biotech Collaborating With Latch Medical on Metabolic Health Technology","media":"MT Newswires Live","content":"<html><body><p> Trinity Biotech (TRIB) said Wednesday it is collaborating with Latch Medical to develop precision therapeutic solutions for diabetes, obesity and other metabolic conditions.</p><p>The companies plan to integrate Trinity's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to explore how real-time metabolic data can be used to help guide and optimize therapeutic delivery.</p><p>Financial terms of the collaboration not disclosed.</p><p>Trinity Biotech also agreed in principle to make a strategic equity investment in Latch Medical as part of the collaboration, the company said.</p><p>Trinity Biotech shares were down 23% in premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trinity Biotech Collaborating With Latch Medical on Metabolic Health Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrinity Biotech Collaborating With Latch Medical on Metabolic Health Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-22 20:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Trinity Biotech (TRIB) said Wednesday it is collaborating with Latch Medical to develop precision therapeutic solutions for diabetes, obesity and other metabolic conditions.</p><p>The companies plan to integrate Trinity's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to explore how real-time metabolic data can be used to help guide and optimize therapeutic delivery.</p><p>Financial terms of the collaboration not disclosed.</p><p>Trinity Biotech also agreed in principle to make a strategic equity investment in Latch Medical as part of the collaboration, the company said.</p><p>Trinity Biotech shares were down 23% in premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRN","symbol_name":"Trinity Industries Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2653175078","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653175078","pubTimestamp":1784723567,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Trinity Biotech  said Wednesday it is collaborating with Latch Medical to develop precision therapeutic solutions for diabetes, obesity and other metabolic conditions.The companies plan to integrate Trinity's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to explore how real-time metabolic data can be used to help guide and optimize therapeutic delivery.Financial terms of the collaboration not disclosed.Trinity Biotech also agreed in principle to make a strategic equity investment in Latch Medical as part of the collaboration, the company said.Trinity Biotech shares were down 23% in premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"TRN":"Trinity Industries Inc","XBI":"SPDR S&P Biotech ETF"},"translate_title":"Trinity Biotech 与 Latch Medical 合作开发代谢健康技术","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":1.5,"TRN":1.5},"content_text":"Trinity Biotech (TRIB) said Wednesday it is collaborating with Latch Medical to develop precision therapeutic solutions for diabetes, obesity and other metabolic conditions.The companies plan to integrate Trinity's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to explore how real-time metabolic data can be used to help guide and optimize therapeutic delivery.Financial terms of the collaboration not disclosed.Trinity Biotech also agreed in principle to make a strategic equity investment in Latch Medical as part of the collaboration, the company said.Trinity Biotech shares were down 23% in premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}